Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Naltrexone: a clinical perspective.

R A Greenstein, I C Arndt, A T McLellan

    The Journal of Clinical Psychiatry
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Accurate and Rapid Electrochemical Detection of Fentanyl in Hydrophobic Ionic Liquid at Subzero Temperatures.

    Electrochimica acta·2025
    Same author

    Effectiveness of non-pharmaceutical interventions as implemented in the UK during the COVID-19 pandemic: a rapid review.

    Journal of public health (Oxford, England)·2025
    Same author

    Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Association, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, Vancouver, BC, Sept. 17-21, 2013.

    Canadian journal of surgery. Journal canadien de chirurgie·2025
    Same author

    OSAIRIS: Lessons Learned From the Hospital-Based Implementation and Evaluation of an Open-Source Deep-Learning Model for Radiotherapy Image Segmentation.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2024
    Same author

    Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.

    Journal of public health (Oxford, England)·2024
    Same author

    Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same journal

    Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

    The Journal of clinical psychiatry·2026
    Same journal

    Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

    The Journal of clinical psychiatry·2026
    Same journal

    Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

    The Journal of clinical psychiatry·2026
    Same journal

    Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

    The Journal of clinical psychiatry·2026
    See all related articles

    Naltrexone, a narcotic antagonist, showed effectiveness in blocking opiate effects for addicts. While some patients increased alcohol use, one-third remained opiate-free six months post-treatment, indicating short-term success.

    Area of Science:

    • Pharmacology
    • Addiction Medicine
    • Clinical Psychology

    Background:

    • Opiate addiction is a significant public health issue.
    • Naltrexone is an opioid antagonist used in addiction treatment.
    • Understanding naltrexone's efficacy and patient factors is crucial for treatment success.

    Purpose of the Study:

    • To evaluate the effectiveness of naltrexone in treating opiate addiction.
    • To identify factors influencing patient retention and treatment outcomes.
    • To assess side effects and relapse patterns during naltrexone therapy.

    Main Methods:

    • A study involving over 300 opiate-addicted patients.
    • Treatment duration varied, with a mean of two months.
    • Patient selection criteria were analyzed for their impact on outcomes.

    Related Experiment Videos

    Main Results:

    • Patient selection significantly impacted retention and outcomes.
    • Most patients experienced satisfactory narcotic blockade when tested.
    • One-third of patients were opiate-free six months after naltrexone cessation.

    Conclusions:

    • Naltrexone demonstrates potential as a short-term treatment modality for opiate addiction.
    • Careful patient selection is vital for optimizing naltrexone treatment.
    • Further research may explore long-term efficacy and management of increased alcohol consumption.